Search Results

0 results for 'Mallinckrodt Pharmaceuticals'

You can use to get even better search results
In re: Mallinckrodt PLC
Publication Date: 2024-01-29
Practice Area: Bankruptcy
Industry: Manufacturing | Pharmaceuticals
Court: U.S. Bankruptcy Court
Judge: Judge Dorsey
Attorneys:
For plaintiff:
For defendant:
Case number: 20-12522 (JTD)

Court rejected invocation of securities safe harbor provision to dismiss fraudulent transfer claims where defendant did not qualify as a financial participant in the transaction as defined by the provision.

October 13, 2023 | Litigation Daily

A Full Slate of Litigator of the Week Runners-Up and Shout Outs

A trial team at Panish | Shea | Boyle | Ravipudi won a $135 million damages verdict for two California men who were sexually abused by their sixth-grade teacher starting in 1996 in a case where the school district was on notice of other child molestation complaints against the teacher years earlier.
6 minute read
October 03, 2023 | New York Law Journal

Litigation Department of the Year Winner: Latham & Watkins

"Latham's litigation department is not just a constellation of top-tier practice groups, but also a genuinely collaborative team that works across practice areas to secure extraordinary results for clients."
4 minute read
September 14, 2023 | New York Law Journal

Pharmaceutical Co. Sues Insurer Over Failure to Indemnify It in Opioid Litigation

Hikma Pharmaceuticals claimed Lloyd's of London has breached a policy to provide coverage given proper notice.
3 minute read
June 08, 2023 | Corporate Counsel

State Attorneys General Flexing Muscles, Posing Growing Risk to Legal Departments

"When acting together, they're another FTC but maybe even worse," said Lori Kalani, co-chair of the state attorneys general practice at Cozen O'Connor.
8 minute read
April 14, 2023 | The Legal Intelligencer

Pharma Board Faces Shareholder Class Action for Opioid Settlements

The plaintiff claimed that Mallinckrodt PLC's board of directors caused class members' stock to lose all value, in part by "refusing to aggressively litigate or vigorously defend opioid lawsuits."
3 minute read
March 02, 2023 | New York Law Journal

Health Care Fraud Tops DOJ's Annual False Claims Act Report—Again!

In this article, insurance fraud columnist Michael A. Sirignano explores the health care-related information in the report in more depth and then discusses how this helps to understand the federal government's FCA enforcement priorities, as well as the priorities that private insurers should be contemplating.
10 minute read
Strougo v. Mallinckrodt Pub. Ltd. Co.
Publication Date: 2022-12-29
Practice Area: Securities Litigation
Industry:
Court: U.S. District Court for New Jersey
Judge: District Judge Shipp
Attorneys:
For plaintiff:
For defendant:
Case number: 20-10100 (MAS) (TJB)

Defendants moved to dismiss lead plaintiff's complaint.

December 22, 2022 | The American Lawyer

'The Human Side:' Shook Hardy Partner Exits to Lead Legal Services Group

"I've checked all the boxes on the private practice side and was really looking for a new challenge," said Matthew Keenan.
13 minute read
Horizon Med. LLC v. Apotex Inc.
Publication Date: 2022-12-06
Practice Area: Patent Litigation
Industry: Pharmaceuticals
Court: U.S. District Court of Delaware
Judge: District Judge Burke
Attorneys:
For plaintiff: Karen E. Keller, Andrew E. Russell, Nathan R. Hoeschen, Emily S. DiBenedetto, Shaw Keller LLP, Wilmington, DE; Sanya Sukduang, Johnathan R. Davis, Allison E. Elkman, Cooley LLP, Washington, DC; Mazda Antia, Erin Trenda, Cooley LLP, San Diego, CA for plaintiffs.
For defendant: Kenneth L. Dorsney, Cortlan S. Hitch, Morris James LLP, Wilmington, DE; Deepro R. Mukerjee, Lance A. Soderstrom, Katten Muchin Rosenman LLP, New York, NY; Joseph M. Janusz, Katten Muchin Rosenman LLP, Charlotte, NC for defendants.
Case number: 22-640-CJB

A patent licensor could issue a license to a future continuation patent that was ultimately not issued to the licensor by expressly including future continuation patents in the scope of the license since permitting the eventual patent owner to sue for infringement of the continuation patent would undermine rights acquired for consideration by the licensee.

TRENDING STORIES

    Resources

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now

    • Practical Guidance Journal: Protecting Work Product in a Generative AI World

      Brought to you by LexisNexis®

      Download Now

    • Countdown to Compliance: SEC Private Fund Reforms

      Brought to you by Ontra

      Download Now